Anixa Biosciences Announces VA North Texas Health Care System To Join Cchek™ Prostate Cancer Study

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system to fight cancer, today announced that the VA North Texas Health Care System and its non-profit affiliate, the Dallas VA Research Corporation, have joined Anixa’s ongoing prostate cancer Cchek™ study.  Study enrollment will be led by Dr. Manoj Reddy, Radiation Oncologist, and Dr. Jeffrey Gahan, Chief of Robotic Surgery.

“We are pleased to see the continued expansion in Cchek™ collaboration partners to now include the VA North Texas Health Care System.  We look forward to working with Dr. Reddy and Dr. Gahan as we further the development of our artificial intelligence based prostate cancer diagnostic test,” stated Dr. Amit Kumar, CEO of Anixa. – Bio Space

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.